2009 Annual Meeting | Neurology Update II

Date Friday 05/01/09

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Karen L. Roos, MD, FAAN

Topic(s) Multiple Sclerosis, Headache, Global Health and Neuroepidemiology, Neuromuscular and Clinical Neurophysiology (EMG), Pain, Women's Issues, Neuro-ophthalmology/Neuro-otology, Sleep

Learning Objectives Participants should have a knowledge of the most current recommendations for the diagnosis and therapy of movement disorders, epilepsy, stroke, dementia, headache, sleep, neuroinfectious diseases, multiple sclerosis, and pain; knowledge of new therapies in neuro-oncology and use of the latest diagnostic tools when evaluating the patient with a neurologic disorder in the ICU; new ideas to improve the care of patients with neuromuscular disorders and neuro-otologic conditions; a better understanding of neuro-ophthalmology; should know the benefits and limitations of the laboratory tests for the ataxias; and have new knowledge and feel more comfortable with the pregnant patient with a neurologic disorder.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:45 AM		Headache Jerry W. Swanson, MD, FAAN
09:45 AM - 10:30 AM		Neuromuscular Disorders Robert M. Pascuzzi, MD, FAAN
10:30 AM - 10:45 AM		Break
10:45 AM - 11:30 AM		Sleep Alon Y. Avidan, MD, MPH, FAAN
11:30 AM - 12:15 PM		Pain Kathleen M. Foley, MD, FAAN
12:15 PM - 01:30 PM		Lunch
01:30 PM - 02:15 PM		Neuro-ophthalmology Nancy J. Newman, MD, FAAN
02:15 PM - 03:00 PM		Neuroinfectious Diseases Russell E. Bartt, MD, FAAN
03:00 PM - 03:45 PM		Neurologic Issues in Pregnancy Cynthia L. Harden, MD
03:45 PM - 04:00 PM		Break
04:00 PM - 04:45 PM		Multiple Sclerosis Elliot M. Frohman, MD, FAAN

Faculty Disclosures
Russell E. Bartt, MD, FAAN	Dr. Bartt has nothing to disclose.
Nancy J. Newman, MD, FAAN	Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Newman has received research support from GenSight. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Robert M. Pascuzzi, MD, FAAN	Dr. Pascuzzi has nothing to disclose.
Alon Y. Avidan, MD, MPH, FAAN	Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avadel. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Avidan has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Harmony. Dr. Avidan has received publishing royalties from a publication relating to health care.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Jerry W. Swanson, MD, FAAN	No disclosure on file
Elliot M. Frohman, MD, FAAN	Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Kathleen M. Foley, MD, FAAN	No disclosure on file
Karen L. Roos, MD, FAAN	No disclosure on file

��ɫ��

��ɫ��